Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADI-PEG 20 in Metastatic Melanoma
NCT00450372Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jun 2004
- Primary completion
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Pegargiminase in melanoma, sponsored by University of Miami. Started Jun 2004; status: completed.
02
Drugs
Pegargiminase
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00450372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450372.